At ICSE 2011, one of the biggest and most important fairs for the global chemical and pharmaceutical community co-located with CPhI Worldwide 2011, Borealis and Borouge will demonstrate their ability to meet all stringent requirements for the healthcare industry, by offering security of supply, dedicated materials, additional support and innovation. Bormed™ dedicated polyolefins meet the highest quality standards and fulfil all regulatory requirements for pharmaceutical and medical applications.
Based on over 30 years of experience in this highly-specialised market, the ever-expanding product range from Borealis and Borouge offers regulatory compliance, special production and quality control procedures, and extended technical support, all anchored by financially strong ownership, to give customers confidence in Bormed. Dedicated Bormed polyolefins for the healthcare market, delivered globally by Borealis and Borouge, are underlined by a long-term commitment to reliability and safety that delivers peace of mind to customers.
Bormed highlights on the stand
During the event, Borealis and Borouge will highlight new opportunities for improved performance and efficiency in the healthcare market. These include Bormed™ LE6609-PH for bottles and ampoules produced by blow, fill and seal (BFS) technology and Bormed™ SC820CF for soft medical film, pouches and tubing.
Bormed LE6609-PH was designed specifically to satisfy the elevated security and performance demand for sterilised products, reductions in material use and more efficient manufacturing. Offering the highest possible density and therefore melting point for a low density polyethylene (LDPE), this transparent BFS Bormed grade allows steam sterilisation at temperatures above 110°C. The high sterilisation temperature allows converters to further reduce autoclave residence time by up to 1.5 hours, speeding up their production cycle, lowering energy use and improving efficiency.
In addition, Bormed LE6609-PH’s high density and optimised molecular weight distribution (MWD) offers the potential for material and weight reduction of up to 5-7%. Converters and brand owners can make more lightweight products using the same material volume, while the resulting energy savings benefit both manufacturing costs and the environment.
Another Bormed development leading the way in creating new opportunities for improved performance and efficiency in the healthcare market is Bormed SC820CF for primary and secondary medical pouches. This random heterophasic polypropylene (PP) copolymer for cast- and blown film applications combines softness with toughness and is steam sterilisable. It also maintains good optical and mechanical properties after retorting. Bormed SC820CF is intended as a blending component or co-extrusion layer for primary pouches with contents such as intravenous (IV) solutions, nutrition and dialysis fluids. Furthermore it is used as part of the solution for secondary wrap films for dust and vapour barrier and protection. This new material contributes to all PP pouch solutions, which serve as a viable alternative to commonly used glass bottles or polyvinyl chloride (PVC) pouches.
“Borealis and Borouge’s presence at ICSE underlines our dedication to the healthcare market,” comments Max Wachholder, Borealis Marketing Manager for Healthcare. “Our focus is to bring peace of mind to the industry’s value chain, from converter to end-user, while providing high-quality and innovative products.”
For more information, please visit Borealis and Borouge at Hall 4.1 Stand K18 or visit borealisgroup.com/healthcare.
Bormed ™ – because we care
With more than 30 years of experience in serving the healthcare market, Borealis understands the industry’s need for reliable global material suppliers and is continually strengthening its support.
Borealis offers dedicated global products, security of supply, innovation and technical support for the specialised and strict requirements of these customers. Its ever-expanding range of dedicated Bormed™ polyolefins focuses on high quality and long-term commitment which is anchored by our financially strong ownership. Polypropylene and polyethylene innovations provide superior technical performance to meet the lightweight, aesthetic and processing and consumer convenience-related demands of the fast-growing medical devices and pharmaceutical and diagnostic packaging markets, independent of conversion technology or polymer type.
The Bormed product range responds to the challenging service requirements of the healthcare industry. Regulatory compliance and special production and quality control procedures are some of the elements that ensure stability, reliability, traceability, consistency and continuity. This gives customers around the world confidence in their use of Bormed materials to advance their application.
About Borealis and Borouge
Borealis is a leading provider of chemical and innovative plastics solutions that create value for society. With sales of EUR 6.3 billion in 2010, customers in over 120 countries, and 5,100 employees worldwide, Borealis is owned 64% by the International Petroleum Investment Company (IPIC) of Abu Dhabi and 36% by OMV, the leading energy group in the European growth belt. Borealis is headquartered in Vienna, Austria, and has production locations, innovation centres and customer service centres across Europe and the Americas.
Through Borouge, a joint venture between Borealis and the Abu Dhabi National Oil Company (ADNOC), one of the world’s major oil and gas companies, the company’s footprint reaches out to the Middle East, Asia Pacific, the Indian sub-continent and Africa. Established in 1998, Borouge employs approximately 1,600 people, has customers in more than 50 countries and its headquarters are in Abu Dhabi in the UAE and Singapore.
Building on Borealis’ unique Borstar® technology and their experience in polyolefins of more than 50 years, Borealis and Borouge provide innovative, value creating plastics solutions for the infrastructure (pipe systems and power and communication cables), automotive and advanced packaging markets. In addition, Borealis offers a wide range of base chemicals from melamine and plant nutrients to phenol and acetone.
Today, Borealis and Borouge have a manufacturing capacity of over 5.4 million tonnes of polyolefins (polyethylene and polypropylene) per year of which 26% are the result of a recently completed capacity expansion in Abu Dhabi. An additional 2.5 million tonnes per year is scheduled for completion by mid-2014, creating the world’s largest integrated polyolefins plant. The companies continue to invest to ensure that their customers throughout the value chain, around the world, can always rely on superior products and security of supply.
Borouge (borealisgroup.com) and Borealis (borouge.com) are committed to the principles of Responsible Care® and proactively contribute to addressing the world’s water and sanitation challenges through their Water for the World™ (waterfortheworld.net) initiative.
Bormed and Water for the World are trademarks of the Borealis group.